1. Home
  2. TXG vs EVV Comparison

TXG vs EVV Comparison

Compare TXG & EVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TXG
  • EVV
  • Stock Information
  • Founded
  • TXG 2012
  • EVV 2003
  • Country
  • TXG United States
  • EVV United States
  • Employees
  • TXG N/A
  • EVV N/A
  • Industry
  • TXG Biotechnology: Laboratory Analytical Instruments
  • EVV Finance/Investors Services
  • Sector
  • TXG Industrials
  • EVV Finance
  • Exchange
  • TXG Nasdaq
  • EVV Nasdaq
  • Market Cap
  • TXG 1.3B
  • EVV 1.2B
  • IPO Year
  • TXG 2019
  • EVV N/A
  • Fundamental
  • Price
  • TXG $8.85
  • EVV $10.14
  • Analyst Decision
  • TXG Buy
  • EVV
  • Analyst Count
  • TXG 16
  • EVV 0
  • Target Price
  • TXG $20.00
  • EVV N/A
  • AVG Volume (30 Days)
  • TXG 3.0M
  • EVV 323.7K
  • Earning Date
  • TXG 04-29-2025
  • EVV 01-01-0001
  • Dividend Yield
  • TXG N/A
  • EVV 9.66%
  • EPS Growth
  • TXG N/A
  • EVV N/A
  • EPS
  • TXG N/A
  • EVV N/A
  • Revenue
  • TXG $610,785,000.00
  • EVV N/A
  • Revenue This Year
  • TXG $1.43
  • EVV N/A
  • Revenue Next Year
  • TXG $8.86
  • EVV N/A
  • P/E Ratio
  • TXG N/A
  • EVV N/A
  • Revenue Growth
  • TXG N/A
  • EVV N/A
  • 52 Week Low
  • TXG $8.53
  • EVV $8.52
  • 52 Week High
  • TXG $37.74
  • EVV $10.07
  • Technical
  • Relative Strength Index (RSI)
  • TXG 33.15
  • EVV 53.07
  • Support Level
  • TXG $9.65
  • EVV $9.97
  • Resistance Level
  • TXG $10.60
  • EVV $10.18
  • Average True Range (ATR)
  • TXG 0.51
  • EVV 0.08
  • MACD
  • TXG -0.06
  • EVV 0.01
  • Stochastic Oscillator
  • TXG 13.68
  • EVV 80.48

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

About EVV Eaton Vance Limited Duration Income Fund of Beneficial Interest

Eaton Vance Ltd Duration Income Fund is a diversified closed-end management investment company. The company's investment objective is to provide a high level of current income. The Fund may, as a secondary objective, also seek capital appreciation. The Fund invests predominantly in Senior Floating-Rate Loans, Debt Obligations, Equity Securities, Derivatives as well as Foreign Securities and Currencies. The Fund invests in various industries, including aerospace and defense, automotive, building and development, healthcare, and leisure among others.

Share on Social Networks: